Company / Gross Profit
Exelixis Gross Profit History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$184.4M
FY2020
5-year range
-
FY2016-FY2020
Trend
+7.2%
vs FY2019
Sector context
#23 of 29
Health Care
What the data says
Exelixis's gross profit of $184M is lower than 79% of companies in the Health Care sector (FY2020). Improved from $92M to $184M over the past 2 years.
Based on SEC 10-K filings.
$184M in FY2020 with a 3-year CAGR of +26.3%.
Improved from $92M to $184M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +26.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 29This company $184.4M Sector average $3.5B
▼
-94.7% below sector average
Key checks
Key Insights
- 3-year CAGR of +26.3%, indicating consistent growth.
- In FY2020, gross profit increased 7.2% year-over-year.
- Ranks #23 out of 29 companies in the Health Care sector.
- Lowest gross profit in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $184.4M | +7.2% |
| FY2019 | $172.1M | +88.0% |
| FY2018 | $91.5M | +0.0% |
| FY2017 | $91.5M | +987.7% |
| FY2016 | $8.4M | -2.4% |
As of FY2020 · SEC 10-K · Updated Jun 30, 2026